Linhao Li Selected Research

Foreign-Body Reaction

10/2021	MSC-derived immunomodulatory extracellular matrix functionalized electrospun fibers for mitigating foreign-body reaction and tendon adhesion.
9/2021	Surface modification of electrospun fibers with mechano-growth factor for mitigating the foreign-body reaction.
1/2021	Cell membrane-biomimetic coating via click-mediated liposome fusion for mitigating the foreign-body reaction.
6/2020	In Vivo Disintegration and Bioresorption of a Nacre-Inspired Graphene-Silk Film Caused by the Foreign-Body Reaction.
1/2019	Effect of stress on corrosion of high-purity magnesium in vitro and in vivo.
1/2018	Surface modification of nanofibrous matrices via layer-by-layer functionalized silk assembly for mitigating the foreign body reaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linhao Li Research Topics

Disease

9	Neoplasms (Cancer) 03/2022 - 03/2012
6	Foreign-Body Reaction 10/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2022 - 04/2012
3	Wounds and Injuries (Trauma) 01/2020 - 01/2016
2	Liver Diseases (Liver Disease) 01/2022 - 01/2019
2	Root Resorption 09/2021 - 01/2020
2	Knee Osteoarthritis 08/2020 - 01/2018
2	Osteoarthritis 08/2020 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 01/2018
1	Virus Diseases (Viral Diseases) 05/2022
1	Glioma (Gliomas) 03/2022
1	Starvation 03/2022
1	Cardiotoxicity 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Nervous System Diseases (Neurological Disorders) 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Insulin Resistance 10/2021
1	Hyperinsulinism (Hyperinsulinemia) 10/2021
1	Glucose Intolerance 10/2021
1	Infections 03/2021
1	Hepatitis A (Hepatitis, Infectious) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Chemical and Drug Induced Liver Injury 12/2020
1	Pathologic Processes 11/2020
1	Cholestasis 01/2020
1	Hypertrophy 10/2019
1	Inflammation (Inflammations) 01/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 12/2020 - 05/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2013
3	Constitutive Androstane ReceptorIBA 01/2022 - 01/2013
3	Biological ProductsIBA 09/2021 - 02/2004
2	Oxygen (Dioxygen)IBA 03/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 01/2022
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 01/2013
2	Phenobarbital (Luminal)FDA Link 01/2022 - 10/2019
2	Capsules (Microcapsules)IBA 10/2021 - 01/2019
2	Insulin (Novolin)FDA Link 10/2021 - 03/2012
2	VaccinesIBA 03/2021 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 01/2021 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 11/2020 - 01/2020
2	Silk FDA Link 06/2020 - 01/2018
1	Neutralizing AntibodiesIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	Antiviral Agents (Antivirals)IBA 05/2022
1	arginyl-glycyl-aspartic acidIBA 03/2022
1	Glucose OxidaseIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	LigandsIBA 03/2022
1	Metal-Organic FrameworksIBA 03/2022
1	AgarIBA 01/2022
1	CarcinogensIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Hepatocyte Nuclear Factor 4IBA 01/2022
1	citrate-binding transport proteinIBA 12/2021
1	SodiumIBA 12/2021
1	Citric Acid (Citrate)FDA LinkGeneric 12/2021
1	Collagen Type I (Type I Collagen)IBA 10/2021
1	Pyruvic Acid (Pyruvate)IBA 10/2021
1	AndrogensIBA 10/2021
1	Dihydrotestosterone (Androstanolone)IBA 10/2021
1	Androgen Receptors (Androgen Receptor)IBA 10/2021
1	CalciumIBA 09/2021
1	PolymersIBA 01/2021
1	StreptavidinIBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	SphingolipidsIBA 12/2020
1	Caspase 3 (Caspase-3)IBA 11/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2020
1	Activating Transcription Factor 2IBA 08/2020
1	GraphiteIBA 06/2020
1	NacreIBA 06/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	SolutionsIBA 01/2020
1	Fibroins (Fibroin)IBA 01/2020
1	ChitosanIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	SilverIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	ProdrugsIBA 10/2019
1	metazachlorIBA 10/2019
1	ElementsIBA 01/2019
1	Conjugated (USP) Estrogens (Premarin)FDA Link 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	2-chloroethyl ethyl sulfideIBA 01/2019
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/2019

Therapy/Procedure

4	Therapeutics 03/2022 - 05/2015
2	Drug Therapy (Chemotherapy) 03/2022 - 01/2022
1	Bioreactors (Bioreactor) 03/2022
1	VAP-cyclo protocol 11/2020